Microsatellite-instability-high Solid Tumor trials recruiting in North Dakota

Fewer than 3 recruiting trials found.

All Microsatellite-instability-high Solid Tumor trials nationally

Cities in North Dakota

Recruiting trials in North Dakota

• A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
  NCT02332668 · Phase: Phase 1, Phase 2 · Ages: 6 Months to 17 Years · Sex: All (male and female) · North Dakota: Fargo